Company Encyclopedia
View More
name
TC Medical
600763.SH
Topchoice Medical Co., Inc. engages in the oral medical service field in China. It is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services for dental medical services. The company was formerly known as Topchoice Medical Investment Co., Inc.
81.81 B
600763.SHMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care ServicesIndustry
Industry Ranking1/8
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE12.21%B
    • Profit Margin17.65%A
    • Gross Margin43.31%B
  • Growth ScoreC
    • Revenue YoY1.25%C
    • Net Profit YoY6.30%C
    • Total Assets YoY0.89%C
    • Net Assets YoY4.57%C
  • Cash ScoreC
    • Cash Flow Margin566.73%C
    • OCF YoY1.25%C
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreB
    • Gearing Ratio25.10%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    TC Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 514 million yuan, a year-on-year increase of 3.16%

    According to the Zhitong Finance APP, TC Medical disclosed its third-quarter report for 2025. The company achieved revenue of 2.29 billion yuan in the first three quarters, a year-on-year increase of 2.56%; net profit attributable to the parent company was 514 million yuan, a year-on-year increase of 3.16%; net profit excluding non-recurring gains and losses was 509 million yuan, a year-on-year increase of 3.09%; basic earnings per share were 1.15 yuan

    Zhitong·
    SH
    600763
    +0.48%
    Zhitong·
    SH
    600763
    +0.48%

    TC Medical: The net profit for the third quarter was 192 million yuan, a year-on-year increase of 2.15%

    TC Medical announced that its revenue for the third quarter was 842 million yuan, a year-on-year increase of 2.34%; net profit was 192 million yuan, a year-on-year increase of 2.15%. Revenue for the first three quarters was 2.29 billion yuan, a year-on-year increase of 2.56%; net profit was 514 million yuan, a year-on-year increase of 3.16%

    Zhitong·
    SH
    600763
    +0.48%
    Zhitong·
    SH
    600763
    +0.48%

    TC Medical released its performance for the first half of the year, with a net profit attributable to the parent company of 321 million yuan, a year-on-year increase of 3.67%

    According to the Zhitong Finance APP, TC Medical released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 1.448 billion yuan, a year-on-year increase of 2.68%. The net profit attributable to shareholders of the listed company was 321 million yuan, a year-on-year increase of 3.67%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 317 million yuan, a year-on-year increase of 3.85%. The basic earnings per share were 0.72 yuan

    Zhitong·
    SH
    600763
    +0.48%
    Zhitong·
    SH
    600763
    +0.48%

    TC Medical: Acquired 100% equity of Shanghai Cunjikou Dental Clinic with a total transaction amount of 46 million yuan

    TC Medical announced that its wholly-owned subsidiary, Tongce Dental Investment, has acquired 99% equity of Shanghai Cunjie Dental Clinic, while Hangzhou Tongsheng Medical Investment Management Co., Ltd. has acquired 1% equity. The total transaction amount is 46 million yuan. The target company is a wholly-owned subsidiary of Shanghai Tongce Dental Hospital Co., Ltd., and this transaction constitutes a related party transaction. The company stated that this acquisition will enhance the brand's influence and visibility in the high-end market, optimize the business regional layout and product service structure

    Zhitong·
    SH
    600763
    +0.48%
    Zhitong·
    SH
    600763
    +0.48%

    Goldman Sachs focuses on "wealthy elderly individuals," brain-computer interfaces, and gene drugs are the future of high-end self-paid medical care in China

    Goldman Sachs believes that the medical expenditures of individuals over 50 years old in China with a net worth exceeding 3 million yuan will become a key driving force for the growth of the domestic high-end medical market. As the size of this demographic gradually expands, it is expected that high-end pharmaceuticals, medical consumables, rehabilitation services, and other fields will benefit, while emerging technologies such as brain-computer interfaces, gene therapies, and rehabilitation robots are likely to see growth opportunities

    Wallstreetcn·
    SZ
    300122
    +0.70%
    SH
    688050
    -0.16%
    SZ
    300142
    +0.34%
    Wallstreetcn·
    SZ
    300122
    +0.70%
    SH
    688050
    -0.16%
    SZ
    300142
    +0.34%
    © 2025 Longbridge｜Disclaimer